Prostate_specific_antigen_values_after_radical_retropubic_prostatectomy_for_adenocarcinoma_of_the_prostate:_impact_of_adjuvant_treatment_(hormonal_and_radiation)._Prostate_specific_antigen_(PSA)_levels_were_obtained_before_and_after_radical_retropubic_prostatectomy_in_192_patients:_78_(41%)_had_pathological_stage_B2_cancer_or_less,_83_(43%)_had_stage_C_or_C+_and_31_(16%)_had_stage_D1_disease._Of_those_with_stages_B2_or_less,_C,_C+_and_D1_disease_82,_86,_65_and_90%,_respectively,_had_postoperative_PSA_values_of_0.2_ng./ml._or_less_(when_first_evaluated_30_or_more_days_postoperatively)._At_1_year_postoperatively_94%_of_the_stages_C_and_C+_cancer_patients_treated_with_adjuvant_radiation_had_PSA_levels_of_0.2_ng./ml._or_less,_which_was_significantly_different_from_those_not_treated_adjuvantly_(p_=_0.02)._This_effect_of_adjuvant_radiation_on_PSA_was_temporary_in_the_small_number_of_patients_with_longer_followup._Adjuvant_orchiectomy_for_stage_D1_lesions_resulted_in_female_PSA_levels_in_virtually_all_cases._This_decrease_may_be_misleading_and_may_reflect_a_direct_hormonal_effect_rather_than_a_decrease_in_tumor_volume._Positive_surgical_margins_did_not_significantly_affect_postoperative_PSA_levels,_possibly_because_of_the_frequent_use_of_adjuvant_treatment.